Fragile X syndrome: Difference between revisions
Jump to navigation
Jump to search
| (22 intermediate revisions by the same user not shown) | |||
| Line 17: | Line 17: | ||
{{SK}}: Martin-bell syndrome; marker X syndrome, escalante's syndrome | {{SK}}: Martin-bell syndrome; marker X syndrome, escalante's syndrome | ||
== [[Fragile X syndrome overview|Overview]] == | ==[[Fragile X syndrome overview|Overview]]== | ||
== [[Fragile X syndrome historical perspective|Historical Perspective]] == | ==[[Fragile X syndrome historical perspective|Historical Perspective]]== | ||
== [[Fragile X syndrome classification|Classification]] == | ==[[Fragile X syndrome classification|Classification]]== | ||
== [[Fragile X syndrome pathophysiology|Pathophysiology]] == | ==[[Fragile X syndrome pathophysiology|Pathophysiology]]== | ||
== [[Fragile X syndrome causes|Causes]] == | ==[[Fragile X syndrome causes|Causes]]== | ||
== [[Fragile X syndrome differential diagnosis|Differentiating Fragile X syndrome from other Diseases]] == | ==[[Fragile X syndrome differential diagnosis|Differentiating Fragile X syndrome from other Diseases]]== | ||
== [[Fragile X syndrome epidemiology and demographics|Epidemiology and Demographics]] == | ==[[Fragile X syndrome epidemiology and demographics|Epidemiology and Demographics]]== | ||
== [[Fragile X syndrome risk factors|Risk Factors]] == | ==[[Fragile X syndrome risk factors|Risk Factors]]== | ||
== [[Fragile X syndrome screening|Screening]] == | ==[[Fragile X syndrome screening|Screening]]== | ||
== [[Fragile X syndrome natural history, complications and prognosis|Natural History, Complications and Prognosis]] == | ==[[Fragile X syndrome natural history, complications and prognosis|Natural History, Complications and Prognosis]]== | ||
=== | ===[[History and Symptoms]]=== | ||
== Treatment == | ===Physical Examination=== | ||
===[[Laboratory findings]]=== | |||
===[[Other diagnostic studies]]=== | |||
==Treatment== | |||
[[Fragile X syndrome medical therapy|Medical Therapy]] | [[Fragile X syndrome primary prevention|Primary Prevention]] | [[Fragile X syndrome secondary prevention|Secondary Prevention]] | [[Fragile X syndrome cost-effectiveness of therapy|Cost Effectiveness of Therapy]] | [[Fragile X syndrome future or investigational therapies|Future or Investigational Therapies]] | [[Fragile X syndrome medical therapy|Medical Therapy]] | [[Fragile X syndrome primary prevention|Primary Prevention]] | [[Fragile X syndrome secondary prevention|Secondary Prevention]] | [[Fragile X syndrome cost-effectiveness of therapy|Cost Effectiveness of Therapy]] | [[Fragile X syndrome future or investigational therapies|Future or Investigational Therapies]] | ||
| Line 68: | Line 57: | ||
==External links== | ==External links== | ||
*[http://www.cdc.gov/ncbddd/single_gene/fragilex.htm CDC’s National Center on Birth Defects and Developmental Disabilities] | *[http://www.cdc.gov/ncbddd/single_gene/fragilex.htm CDC’s National Center on Birth Defects and Developmental Disabilities] | ||
Latest revision as of 11:22, 3 January 2022
For patient information click here
| Fragile X syndrome | |
 | |
|---|---|
| Location of FMR1 gene | |
| ICD-10 | Q99.2 |
| ICD-9 | 759.83 |
| OMIM | 309550 |
| DiseasesDB | 4973 |
| MeSH | D005600 |
|
Fragile X syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Fragile X syndrome On the Web |
|
American Roentgen Ray Society Images of Fragile X syndrome |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Synonyms and keywords:: Martin-bell syndrome; marker X syndrome, escalante's syndrome
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Fragile X syndrome from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
History and Symptoms
Physical Examination
Laboratory findings
Other diagnostic studies
Treatment
Medical Therapy | Primary Prevention | Secondary Prevention | Cost Effectiveness of Therapy | Future or Investigational Therapies
Case Studies
External links
Template:Pervasive developmental disorders Template:Chromosomal abnormalities